(Q34273131)

1 August 2017

Treatment of Nonalcoholic Fatty Liver Disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

1 August 2017

1 reference

Suthat Liangpunsakul

1

1 reference

PubMed ID

14585234

1 August 2017

Naga Chalasani

series ordinal

2

1 reference

1 August 2017

1 December 2003

1 reference

Current treatment options in gastroenterology

1 August 2017

1 reference

1 August 2017

6

1 reference

1 August 2017

455-463

1 reference

1 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s11938-003-0047-0

1 August 2017

0 references

cites work

Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease

1 reference

12 December 2020

Orlistat in the treatment of NASH: a case series

1 reference

12 December 2020

Probucol in the treatment of non-alcoholic steatohepatitis: a double-blind randomized controlled study

1 reference

12 December 2020

Prevalence of and risk factors for hepatic steatosis in Northern Italy

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Metformin in non-alcoholic steatohepatitis.

1 reference

12 December 2020

Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity

1 reference

12 December 2020

American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease

1 reference

12 December 2020

Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study

1 reference

12 December 2020

Animal models of steatosis

1 reference

12 December 2020

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

12 December 2020

Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults

1 reference

12 December 2020

Nonalcoholic steatohepatitis in obesity: a reversible condition

1 reference

12 December 2020

Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss.

1 reference

12 December 2020

A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

1 reference

12 December 2020

AGA technical review on nonalcoholic fatty liver disease

1 reference

12 December 2020

Liver pathology in morbidly obese patients with and without diabetes

1 reference

12 December 2020

Liver histology in a 'normal' population--examinations of 503 consecutive fatal traffic casualties

1 reference

12 December 2020

Cytokines in alcoholic and nonalcoholic steatohepatitis

1 reference

12 December 2020

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

1 reference

12 December 2020

Update on nonalcoholic fatty liver disease

1 reference

12 December 2020

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

1 reference

12 December 2020

Liver and biliary ultrasonography in diabetic and non-diabetic obese women

1 reference

12 December 2020

Hepatic steatosis after intestinal bypass--prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition

1 reference

12 December 2020

Hepatic effects of dietary weight loss in morbidly obese subjects.

1 reference

12 December 2020

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

1 reference

12 December 2020

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

12 December 2020

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

12 December 2020

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study

1 reference

12 December 2020

Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty

1 reference

12 December 2020

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

1 reference

12 December 2020

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

1 reference

12 December 2020

Ursodeoxycholic acid therapy in hepatobiliary disease

1 reference

12 December 2020

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

12 December 2020

Effect of weight reduction on hepatic abnormalities in overweight patients.

1 reference

12 December 2020

Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Effect of a moderately energy-restricted diet on obese patients with fatty liver

1 reference

12 December 2020

Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis

1 reference

12 December 2020

Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services.

1 reference

12 December 2020

Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases.

1 reference

12 December 2020

Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis

1 reference

12 December 2020

Dietary betaine promotes generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration

1 reference

12 December 2020

Association of nonalcoholic fatty liver disease with insulin resistance.

1 reference

12 December 2020

10.1007/S11938-003-0047-0

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

14585234